Albemarle Co. (NYSE:ALB – Get Free Report) has earned a consensus rating of “Hold” from the twenty ratings firms that are presently covering the company, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and ten have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $152.95.
Several equities research analysts recently weighed in on the company. Oppenheimer decreased their price target on Albemarle from $188.00 to $178.00 and set an “outperform” rating for the company in a report on Tuesday. Wells Fargo & Company increased their price target on Albemarle from $135.00 to $145.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. UBS Group reduced their target price on Albemarle from $124.00 to $109.00 and set a “neutral” rating for the company in a report on Tuesday. Loop Capital reduced their target price on Albemarle from $168.00 to $162.00 and set a “buy” rating for the company in a report on Friday, March 15th. Finally, Robert W. Baird reduced their target price on Albemarle from $170.00 to $127.00 and set an “outperform” rating for the company in a report on Tuesday.
Read Our Latest Research Report on Albemarle
Insider Buying and Selling
Institutional Trading of Albemarle
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ALB. Capital Research Global Investors grew its holdings in Albemarle by 128.5% in the 4th quarter. Capital Research Global Investors now owns 7,076,357 shares of the specialty chemicals company’s stock valued at $1,022,420,000 after buying an additional 3,979,885 shares during the period. Jane Street Group LLC grew its holdings in Albemarle by 176.6% in the 1st quarter. Jane Street Group LLC now owns 1,588,986 shares of the specialty chemicals company’s stock valued at $209,333,000 after buying an additional 3,662,117 shares during the period. Norges Bank purchased a new stake in shares of Albemarle during the 4th quarter worth about $377,341,000. Franklin Resources Inc. grew its holdings in shares of Albemarle by 47.4% during the 4th quarter. Franklin Resources Inc. now owns 5,185,734 shares of the specialty chemicals company’s stock worth $749,235,000 after purchasing an additional 1,667,164 shares during the period. Finally, Capital International Investors grew its holdings in shares of Albemarle by 31.7% during the 4th quarter. Capital International Investors now owns 5,800,219 shares of the specialty chemicals company’s stock worth $838,025,000 after purchasing an additional 1,396,624 shares during the period. Hedge funds and other institutional investors own 92.87% of the company’s stock.
Albemarle Stock Performance
Shares of ALB opened at $90.46 on Wednesday. The company has a current ratio of 2.84, a quick ratio of 1.91 and a debt-to-equity ratio of 0.37. The company’s 50 day simple moving average is $114.76 and its 200-day simple moving average is $121.00. Albemarle has a 12-month low of $90.32 and a 12-month high of $247.44. The firm has a market cap of $10.63 billion, a PE ratio of 32.89, a price-to-earnings-growth ratio of 2.97 and a beta of 1.57.
Albemarle (NYSE:ALB – Get Free Report) last issued its quarterly earnings results on Thursday, May 2nd. The specialty chemicals company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.09). Albemarle had a return on equity of 14.53% and a net margin of 4.02%. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. During the same period in the prior year, the business earned $10.32 earnings per share. Albemarle’s revenue for the quarter was down 47.3% compared to the same quarter last year. As a group, equities analysts predict that Albemarle will post 2.07 EPS for the current year.
Albemarle Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, July 1st. Investors of record on Friday, June 14th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date was Friday, June 14th. Albemarle’s dividend payout ratio is presently 58.18%.
About Albemarle
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Featured Articles
- Five stocks we like better than Albemarle
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Insider-Buy Stocks to Add to Your Watchlist Now
- How to Calculate Inflation Rate
- Commvault Stock: AI Cybersecurity Giant Ready to Double Again
- 3 Warren Buffett Stocks to Buy Now
- Intuit Stock Ready to Soar: RBC Sees Big Upside with GenAI
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.